Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Cancer Gene Therapy
|
July 31, 2001
Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myeloma
X Y Wen, S Mandelbaum, Z H Li, et al.
Leukemia
|
May 23, 2001
Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma--a phase 1 study
S Trudel, Z Li, C Dodgson, et al.
Cancer Gene Therapy
|
October 27, 2012
HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice
S H MacLeod, M M Elgadi, G Bossi, et al.
The EMBO Journal
|
September 1, 1989
EBV gene expression in an NPC-related tumour
M M Hitt, M J Allday, T Hara, et al.
Cancers
|
July 14, 2023
Radiation-Induced Cellular Senescence Reduces Susceptibility of Glioblastoma Cells to Oncolytic Vaccinia Virus
Quinn T Storozynsky, Xuefei Han, Shae Komant, et al.
Plos One
|
March 18, 2024
Oncolytic vaccinia virus immunotherapy antagonizes image-guided radiotherapy in mouse mammary tumor models
Brittany A Umer, Ryan S Noyce, Quinten Kieser, et al.
International Journal of Molecular Sciences
|
July 18, 2019
RUNX3 Promotes the Tumorigenic Phenotype in KGN, a Human Granulosa Cell Tumor-Derived Cell Line
Huachen Chen, Powel Crosley, Abul K Azad, et al.
Blood Cancer Journal
|
August 14, 2012
Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma
P Gelebart, S A Hegazy, P Wang, et al.
International Journal of Molecular Sciences
|
May 5, 2021
Procaspase-Activating Compound-1 Synergizes with TRAIL to Induce Apoptosis in Established Granulosa Cell Tumor Cell Line (KGN) and Explanted Patient Granulosa Cell Tumor Cells In Vitro
Powel Crosley, Anniina Farkkila, Adrianne L Jenner, et al.
EMBO Molecular Medicine
|
March 15, 2017
Deletion of <i>F4L</i> (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer models
Kyle G Potts, Chad R Irwin, Nicole A Favis, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Cancer Gene Therapy
|
July 31, 2001
Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myeloma
X Y Wen, S Mandelbaum, Z H Li, et al.
Leukemia
|
May 23, 2001
Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma--a phase 1 study
S Trudel, Z Li, C Dodgson, et al.
Cancer Gene Therapy
|
October 27, 2012
HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice
S H MacLeod, M M Elgadi, G Bossi, et al.
The EMBO Journal
|
September 1, 1989
EBV gene expression in an NPC-related tumour
M M Hitt, M J Allday, T Hara, et al.
Cancers
|
July 14, 2023
Radiation-Induced Cellular Senescence Reduces Susceptibility of Glioblastoma Cells to Oncolytic Vaccinia Virus
Quinn T Storozynsky, Xuefei Han, Shae Komant, et al.
Plos One
|
March 18, 2024
Oncolytic vaccinia virus immunotherapy antagonizes image-guided radiotherapy in mouse mammary tumor models
Brittany A Umer, Ryan S Noyce, Quinten Kieser, et al.
International Journal of Molecular Sciences
|
July 18, 2019
RUNX3 Promotes the Tumorigenic Phenotype in KGN, a Human Granulosa Cell Tumor-Derived Cell Line
Huachen Chen, Powel Crosley, Abul K Azad, et al.
Blood Cancer Journal
|
August 14, 2012
Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma
P Gelebart, S A Hegazy, P Wang, et al.
International Journal of Molecular Sciences
|
May 5, 2021
Procaspase-Activating Compound-1 Synergizes with TRAIL to Induce Apoptosis in Established Granulosa Cell Tumor Cell Line (KGN) and Explanted Patient Granulosa Cell Tumor Cells In Vitro
Powel Crosley, Anniina Farkkila, Adrianne L Jenner, et al.
EMBO Molecular Medicine
|
March 15, 2017
Deletion of <i>F4L</i> (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer models
Kyle G Potts, Chad R Irwin, Nicole A Favis, et al.
Page
of 10